About Protein Metrics

Advancing Scientific Discovery

Protein Metrics provides a platform solution for biotherapeutic analytical study from research through to industrial production. Whether it is identifying proteins for proteomics or providing comprehensive data analysis, our proprietary algorithms offer deeper insights and more accurate results.

Our Story

We have been committed to understanding protein science and biopharma development since our inception. Our expertise in algorithm design and software engineering allows us to apply novel approaches to designing data platforms and provide customers with greater insights into their research.
Biotherapeutic protein characterization and proteomics are critical to innovation in biomarker and biologic drug discovery, vaccines, and therapeutic products. Protein Metrics' mission is to cut through the mountains of data, making life easier for analysts at all stages of research.
Our sophisticated software allows scientists to perform highly accurate analyses on the data generated from all major commercially available liquid chromatography, capillary electrophoresis, and mass spectrometry platforms. Underpinned by 30 patents, the products’ unique algorithms are designed to help researchers minimize ambiguity, achieve reproducibility, and eliminate lab-to-lab variability.
As part of Dotmatics, we benefit from a collaborative environment, leveraging best-in-breed applications across various scientific techniques. Our focus is on ensuring software keeps pace with advanced instrumentation, integrating data seamlessly to support better decision-making and accelerate the development of biologics.

Trusted by the world’s leading research organizations

Meet Our Leadership Team

Steve Cypes

President

As President, Steve drives Protein Metrics’ continued growth and leadership in biologics characterization, delivering best-in-class software solutions to both industry and academia. Since joining the Protein Metrics Leadership Team in 2021, he has led Global Sales, Customer Success, and Enterprise Services, and has guided the business through its integration with Dotmatics and Siemens.

With more than 20 years of experience leading teams to develop and commercialize disruptive technologies across the Life Sciences and Materials Science industries, Steve has consistently focused on empowering scientists to accelerate R&D and innovation. Before joining Protein Metrics, he served as Vice President of Workflow Sales at Unchained Labs, overseeing global sales for the company’s automated, high-throughput workflow products. Earlier in his career, Steve held leadership roles at Freeslate (acquired by Unchained Labs in 2016) as VP of Business Development, and at Symyx Technologies, where he served in positions spanning Engineering, Product Management, and Sales.

Steve holds B.S. and M.Eng. degrees in Chemical Engineering from Cornell University, and an M.B.A. from Cornell’s Johnson Graduate School of Management.

Marshall Bern, Ph.D.

VP of Research / Co-Founder

Marshall Bern is an obsessive problem solver, starting with chess and bridge in high school and college, and later in scientific pursuits including signal and image processing, combinatorial optimization, computational geometry, and bioinformatics. His particular passion is algorithm design and analysis.

Prior to Protein Metrics, Marshall was a Principal Scientist, Xerox Palo Alto Research Center (PARC), where he invented groundbreaking algorithms for origami design, finite-element mesh generation, and surface reconstruction from scanned point sets. He has about 20 patents and about 200 peer-reviewed publications in leading computer science, mathematics, and chemistry journals.

Marshall received a B.A. in mathematics from Yale, M.A. in applied mathematics and statistics from University of Texas at Austin, and a Ph.D. in computer science from the University of California, Berkeley.

Yong Kil, Ph.D.

VP of Architecture / Co-Founder

Yong’s passions for scientific visualization and massive data analysis inspired him to co-found Protein Metrics.

With a keen understanding of proteomics and mass spectrometry, he works tirelessly to create consumer-like software interfaces within the industrial software engineering experience.

Yong received his Ph.D. in computer science from the University of California, Davis.

When he’s not glued to his computer screen, Yong can be found hiking, rock climbing, or hitting the slopes.

Mojgan Haddad, Ph.D.

Vice President of Engineering

Mojgan has held leadership positions of Software and Bioinformatics teams at Corin Group, Talis Biomedical, HealthTell, and Monogram Biosciences (a LabCorp company). Mojgan received her Ph.D. in Computer Science and her Master’s in Computer Science and Artificial Intelligence from Vienna University of Technology in Austria, and completed a postdoctoral fellowship at University of California San Francisco (UCSF) in Mathematical and Computational Biology.

She has published extensively in the area of data science and machine learning for personalized medicine, and is also an inventor of multiple patents.

St John Skilton, Ph.D

VP Product Strategy and Marketing

St John has been at the forefront of product development for many years, with deep domain experience in MS,related analytical tools and the biopharmaceutical industry,

Previously at Danaher, Waters, Micromass and other startups, St John has extensive experience in bringing new products to market. His experience in sales, marketing, business development, and analyst roles has helped provide a rounded view of product portfolios and how to deliver tools that are meaningful for customers.

St John studied Chemical Engineering and Chemistry at the University of Cape Town, and has a PhD from the University of Fribourg. He has been an author on many papers and with an affinity for languages has lived in the U.K. France, Italy, Switzerland, Japan, Korea and South Africa.

Ilker Sen, Ph.D.

VP, Customer Success and Services

Ilker is passionate about bridging the gap between cutting-edge science and practical application. He holds a B.S. in Physics, a Ph.D. in Molecular Biophysics, and has held postdoctoral roles at National High Magnetic Field Laboratory and Albert Einstein College of Medicine. His background spans the spectrum of biopharmaceutical sciences from research to development, with particular emphasis on experimental and computational structural biology, proteomics, and mass spectrometry. At Protein Metrics, Ilker has built customer success from the ground up, leading global operations that support scientists across continents.

Prior to joining Protein Metrics, Ilker was a scientist at Johnson & Johnson, where he developed end-to-end automated workflows to characterize biotherapeutics, sourced new therapeutic candidates using novel antibody de novo sequencing methods, and determined structure and dynamics of protein complexes using Hydrogen-deuterium exchange mass spectrometry and computational biology. Today, Ilker is committed to ensuring that scientists have the tools and support needed to advance the next generation of biologics.

In 2022, Protein Metrics became part of Dotmatics, the world’s largest and most powerful scientific R&D software platform.
Combining an open data informatics framework with best in breed applications like GraphPad Prism, Geneious, SnapGene and OMIQ, Dotmatics offers the first true end-to-end solutions for biology, chemistry, formulations, data management, flow cytometry, and more.

Get started with Protein Metrics